Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27947
Full metadata record
DC FieldValueLanguage
dc.contributor.authorScott, Andrew M-
dc.contributor.authorCzernin, Johannes-
dc.date.accessioned2021-11-08T23:22:50Z-
dc.date.available2021-11-08T23:22:50Z-
dc.date.issued2021-
dc.identifier.citationJournal of nuclear medicine : official publication, Society of Nuclear Medicine 2021-11; 62(11): 1492-1494en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/27947-
dc.language.isoeng-
dc.titlePerspectives on Theranostics and Nuclear Medicine: A Conversation Between Andrew Scott and Johannes Czernin.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Nuclear Medicineen
dc.identifier.affiliationAustin Healthen
dc.identifier.affiliationDavid Geffen School of Medicine at UCLA, Los Angeles, Californiaen
dc.identifier.doi10.2967/jnumed.121.263243en
dc.type.contentTexten
dc.identifier.pubmedid34725232-
local.name.researcherScott, Andrew M
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

28
checked on Nov 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.